Clinical Trial Update: Safety and Efficacy of Revlimid® (Lenalidomide) With Mabthera® (Rituximab) in Non-Hodgkin's Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating lenalidomide with rituximab in non-Hodgkin lymphoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma

Drugs mentioned

• MabThera (rituximab)
• Revlimid (lenalidomide)

Snippet

Sponsor: Institut Paoli-Calmettes | Conditions: Non-Hodgkin Lymphoma | Phase 2 | Status: COMPLETED